NASDAQ:SNOA - Sonoma Pharmaceuticals Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$6.15
▼ -0.13 (-2.07%)

This chart shows the closing price for SNOA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sonoma Pharmaceuticals Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SNOA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SNOA

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Sonoma Pharmaceuticals in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $6.15.

This chart shows the closing price for SNOA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Sonoma Pharmaceuticals. This rating has held steady since November 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2018Maxim GroupReiterated RatingHoldHigh
7/20/2018BenchmarkReiterated RatingSpeculative Buy$3.00Medium
3/5/2018Maxim GroupDowngradeBuy ➝ Hold$7.00Low
2/14/2018Maxim GroupReiterated RatingBuy ➝ Buy$11.00 ➝ $7.00Low
2/8/2018Maxim GroupSet Price TargetBuy$11.00 ➝ $7.00High
12/28/2017BenchmarkInitiated CoverageSpeculative Buy ➝ Speculative Buy$10.00High
11/17/2017Maxim GroupSet Price TargetBuy$11.00N/A
11/10/2017Maxim GroupBoost Price TargetBuy$10.00 ➝ $11.00N/A
8/9/2017Maxim GroupSet Price TargetBuy$10.00High
6/6/2017Maxim GroupReiterated RatingBuy ➝ Buy$9.00 ➝ $10.00Low
2/16/2017Maxim GroupReiterated RatingBuy$8.00 ➝ $9.00N/A
2/10/2017Maxim GroupBoost Price Target$9.00N/A
11/11/2016Maxim GroupSet Price TargetBuy$8.00N/A
11/1/2016Maxim GroupBoost Price TargetBuy$7.00 ➝ $8.00N/A
8/11/2016Maxim GroupReiterated RatingBuy$7.00N/A
(Data available from 7/28/2016 forward)
Sonoma Pharmaceuticals logo
Sonoma Pharmaceuticals, Inc. engages in developing and producing Stabilized Hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. Its products educe infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA.
Read More

Today's Range

Now: $6.15
Low: $6.10
High: $6.42

50 Day Range

MA: $7.37
Low: $5.91
High: $8.89

52 Week Range

Now: $6.15
Low: $5.36
High: $15.19

Volume

17,506 shs

Average Volume

173,956 shs

Market Capitalization

$12.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Frequently Asked Questions

What sell-side analysts currently cover shares of Sonoma Pharmaceuticals?

The following Wall Street sell-side analysts have issued stock ratings on Sonoma Pharmaceuticals in the last twelve months:
View the latest analyst ratings for SNOA.

What is the current price target for Sonoma Pharmaceuticals?

0 Wall Street analysts have set twelve-month price targets for Sonoma Pharmaceuticals in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Sonoma Pharmaceuticals in the next year.
View the latest price targets for SNOA.

What is the current consensus analyst rating for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SNOA.

What other companies compete with Sonoma Pharmaceuticals?

How do I contact Sonoma Pharmaceuticals' investor relations team?

Sonoma Pharmaceuticals' physical mailing address is 645 MOLLY LANE SUITE 150, WOODSTOCK GA, 30189. The company's listed phone number is (800) 759-9305 and its investor relations email address is [email protected] The official website for Sonoma Pharmaceuticals is www.sonomapharma.com.